A clinical trial on SAARANAI CHOORANAM in the management of RATHTHA KOTHIPPU (SYSTEMIC HYPERTENSION)
Phase 2
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2022/03/040776
- Lead Sponsor
- Government siddha medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient presenting with the conditions such as known systemic hypertension - Stage II (>=140/ >=90 mm/hg), AHA, Hyperlipidemia, Diabetic mellitus - Type II, Choronic alcoholism, Smoking.
Exclusion Criteria
1.Age group below 34 years and above 71 years.
2.Patients presenting with the following conditions, such as Known malignant Hypertension, Ischaemic heart disease, Chronic kidney disease, Chronic liver disease, Pregnancy, Lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcome will be aimed at reducing the systemic hypertension. If during or after treatment systolic blood pressure below or equal to 130mmHg and diastolic blood pressure below or equal to 90mmHg it will be considered as successful outcome.Timepoint: 45 days
- Secondary Outcome Measures
Name Time Method 1.To evaluate the pharmacological activities of trial drug. <br/ ><br>2.Study about the prevalance of Raththa kothippu (Systemic Hypertension) in relation between diet and life style. <br/ ><br>3.To evaluate safety profile for acute and sub acute toxicity of trail drug. <br/ ><br>4.To perform biochemical analysis. <br/ ><br>Timepoint: 45 days